The Clarity Diagnostics COVID-19 Antigen Rapid Test Kit provides a fast, reliable, and highly accurate lateral flow immunoassay for the qualitative detection of SARS-CoV-2 nucleocapsid protein antigen in direct anterior nasal swab specimens. Accredited with CLIA-waived status, this point-of-care diagnostic test allows healthcare providers to quickly identify active viral infections during the acute phase of illness. Designed for simple execution without complex laboratory instrumentation, the kit includes pre-filled extraction buffer tubes, sterile swabs, and test cassettes, delivering clear visual results within 15 minutes to support rapid clinical triage, infection control, and patient management.
